CK5

CK5 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 28, 2026: “Vaccine eased metabolic problems and extended life in mice”.

Intervention

1 paper studies it3 findingsUpdated

1 new paper in 30 daysSee all 1 papers on CK5

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: People's Government of Jilin Province
  • Animals1

What did studies of CK5 find?

3

Studies of CK5 measured 3 outcomes: cytotoxic T-lymphocyte responses against senescent targets, antigen cross-presentation and dendritic cell senescence.

Cytotoxic T-lymphocyte responses against senescent targets

upin mice1

1 study
  1. CK5 increases cytotoxic T-lymphocyte responses against senescent targets in mice with CpG.

    “synergizes with CpG to elicit potent cytotoxic T-lymphocyte responses against senescent targets.”

    Animalswith CpG

    Vaccine eased metabolic problems and extended life in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Antigen cross-presentation

upin mice1

1 study
  1. CK5 improves antigen cross-presentation in mice.

    “This intervention attenuates aged DC phenotypes, restores antigen cross-presentation”

    Animalsdendritic cell

    Vaccine eased metabolic problems and extended life in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

dendritic cell senescence

downin mice1

1 study
  1. CK5 decreases dendritic cell senescence in mice.

    “This intervention attenuates aged DC phenotypes”

    Animalsdendritic cell

    Vaccine eased metabolic problems and extended life in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months
Advanced Science

Vaccine eased metabolic problems and extended life in mice

Experiments across multiple aging mouse models found that a vaccine cleared targeted fat cells in senescence, a state in which cells stop dividing.Experiments across multiple aging mouse models found that a vaccine cleared targeted fat cells in senescence, a state in which cells stop dividing.

Mouse studyInterventions